KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Sales (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Return on Sales for 4 consecutive years, with 4.12% as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Return on Sales fell 236.0% year-over-year to 4.12%, compared with a TTM value of 4.12% through Dec 2023, up 29.0%, and an annual FY2024 reading of 5819.46%, down 378128.0% over the prior year.
  • Return on Sales was 4.12% for Q4 2023 at Ginkgo Bioworks Holdings, up from 5.46% in the prior quarter.
  • Across five years, Return on Sales topped out at 100.78% in Q4 2020 and bottomed at 11.71% in Q4 2021.
  • Average Return on Sales over 4 years is 3.41%, with a median of 2.56% recorded in 2020.
  • The sharpest move saw Return on Sales tumbled -11249bps in 2021, then skyrocketed 995bps in 2022.
  • Year by year, Return on Sales stood at 100.78% in 2020, then crashed by -112bps to 11.71% in 2021, then soared by 85bps to 1.76% in 2022, then plummeted by -134bps to 4.12% in 2023.
  • Business Quant data shows Return on Sales for DNA at 4.12% in Q4 2023, 5.46% in Q3 2023, and 2.15% in Q2 2023.